)
Beijing Scitop Bio-tech Co (300858) investor relations material
Beijing Scitop Bio-tech Co Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for H1 2026 reached ¥169.51 million, up 3.77% year-over-year, while net profit attributable to shareholders dropped 39.09% to ¥25.10 million due to increased expenses from new production capacity and slower-than-expected ramp-up.
The company maintained its leading position in probiotics, expanded domestic and international markets, and saw robust growth in animal and plant microecological products.
Major investments in R&D and production bases continued, with significant progress in innovation and industry collaboration.
Financial highlights
Operating income: ¥169.51 million, up 3.77% year-over-year.
Net profit attributable to shareholders: ¥25.10 million, down 39.09% year-over-year.
Operating cash flow: ¥10.16 million, down 63.55% year-over-year.
Gross margin: 47.09%, down 2.15 percentage points year-over-year.
Basic and diluted EPS: ¥0.10, down 37.5% year-over-year.
Outlook and guidance
Management expects continued strong demand for probiotics and microecological products, with industry growth driven by health awareness and regulatory support.
New production capacity is expected to gradually improve profitability as utilization increases.
- Revenue up 20.85%, net profit stable, probiotics and microecological agents drive growth.300858
Q4 2025 - Revenue grew but net profit declined; share repurchase plan up to ¥150 million announced.300858
Q1 2026 - Q3 2025 saw strong revenue and profit growth, with major R&D and capacity investments.300858
Q3 2025 - Revenue up 18.32% YoY, net profit down 5.31% amid capacity investment and strong microecological growth.300858
Q2 2025 - Probiotic revenue surged 20.85% year-over-year, driving record net profit and cash flow.300858
Q4 2024 - Net profit rose 7.89% year-over-year, driven by strong probiotics and microecological growth.300858
Q2 2024 - Q3 2024 saw higher revenue but lower net profit, with improved cash flow and rising expenses.300858
Q3 2024 - Q1 2025 saw robust revenue and profit growth, but operating cash flow turned negative.300858
Q1 2025
Next Beijing Scitop Bio-tech Co earnings date
Next Beijing Scitop Bio-tech Co earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage